510(k) Report

510(k) · Cleared

Cleared

Bioactys

K082286510(k) AbbreviatedCleared Feb 24, 2009197-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Graftys · LYC Bone Grafting Material, Synthetic

Cleared on Feb 24, 2009 as substantially equivalent to K051885 (Biomatlante, 2005) and 1 other predicate after a 197-day review. Its family tree reaches back 6 generations to 1999. 1 later device descends from it.

Decided
Feb 24, 2009
Review
197 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K990131 (1999). 8 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 6 generations backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
  2. 5 generations backK020986 Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc. · 2002
  3. 4 generations backK032268 MBCPBiomatlante · 2003
  4. 3 generations backK043005 Modification to MBCPBiomatlante · 2005
  5. 2 generations backK051774 MBCPBiomatlante · 2006
  6. 1 generation backK073064 Graftys BCPGraftys · 2008
  7. This deviceK082286 BioactysGraftys · 2009
  8. Descendant · cites it directly · 0 of its ownK103820 Reprobone Dental Grafting MaterialCeramisys, Ltd. · 2011

Most influential descendants

Showing 1 of 1 · See all
  • K103820Reprobone Dental Grafting MaterialCeramisys, Ltd. · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K990131Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl.1999—
−5K020986Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc.2002—
−4K032268MBCPBiomatlante2003—
−3K043005Modification to MBCPBiomatlante2005—
−2K051774MBCPBiomatlante2006—
−1K073064Graftys BCPGraftys2008—
0 (this device)K082286BioactysGraftys2009—
+1K103820Reprobone Dental Grafting MaterialCeramisys, Ltd.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
FIG. 1 — Lineage of K082286, 1999–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051885MBCP
Summary page 1
…Legally Marketed Predicate'Device TM Predicate MBCP _Resorbable calcium salt bone void filler device [K051885] GRAFTYS®BCP- Resorbable calcium salt bone void filler device [K073064] 4. Device Description…
Biomatlante2005—
*K073064Graftys BCP
Summary page 1
…MBCP _Resorbable calcium salt bone void filler device [K051885] GRAFTYS®BCP- Resorbable calcium salt bone void filler device [K073064] 4. Device Description BIOACTYS® is a sterile single use bioresorbable bone void filling substitute. BIOACTYS…
Graftys2008—

Also cleared against K051885: 13 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K103820Reprobone Dental Grafting MaterialCeramisys, Ltd.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K103820 (Ceramisys, Ltd., 2011) has gone furthest, with 0 descendants of its own.
  • 13 other devices also cite its predicate K051885.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

Bioactys ® is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.

These defects may be surgically created osseous or defects created from traumatic injury to bone.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082286: Bioactys.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K082286

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026